Dan Suesskind
Angel Investor
Dan Suesskind is a seed investor focused on Men's and Medical. Dan S. Suesskind joined Israel Corp.’s Board in November 2011. He currently serves as a director of several companies, including Teva, Migdal Insurance Company Ltd. and Syneron Medical Ltd., as well as a member of the board (and finance and investment committee) of the Jerusalem Foundation, a member of the Investment Committee of the Israell Academy of Science and Humanities and the Board of Trustees of the Hebrew University. Prior to joining Teva’s Board in January 2010, he was Teva’s Chief Financial Officer from 1977 until 2008. He also served as a director of Teva from 1981 to 2001. From 2004 to 2011 he was a director of Ness Technologies Inc. He is one of the founders and a member of the steering committee of the Israeli Forum of Chief Financial Officers.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Dan Suesskind invests in
Stages Dan Suesskind invests in
Countries Dan Suesskind invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Men's 1 (100%)
- Medical 1 (100%)
- Health Care 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Butterfly Medical is a medical-device start-up that aims to improve the standard of care for men suffering from Benign Prostate Hyperplasia (BPH) or enlarged prostate. The company has developed a fast, simple and minimally invasive alternative treatment to first-line BPH medication and surgery. Butterfly Medical’s patented device can beplaced in under 10 minutes, in-office, under local anesthesia, without surgical incision, heating or prostate tissue removal. The device aims to be the only in-office BPH treatment that delivers a long-term, effective solution with minimal side effects, requiring no hospitalization or general anesthesia. Early results from clinical trials are very promising with blocked urethras successfully opened and patients suffering no side effects. Further clinical studies are starting in leading medical centers in Europe.Visit www.butterfly-medical.com for more information. | $2M / Seed / Jan 29, 2020 |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Dan Suesskind invest in?
Dan Suesskind invests primarily in Men's, Medical and Health Care startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Dan Suesskind?
Public channels for Dan Suesskind include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Dan Suesskind last invest?
The most recent investment recorded for Dan Suesskind closed in Jan 2020. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
